Dunhill Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63 Buy
46
+45
+4,500% +$2.17K ﹤0.01% 1591
2026
Q2
$80 Hold
1
– – ﹤0.01% 1437
2026
Q1
$44 Hold
1
– – ﹤0.01% 1642
2025
Q4
$58 Buy
+1
New +$40 ﹤0.01% 1609

Other funds holding VCYT

Dunhill Financial's VCYT Position: Q3 2026 in Review

Dunhill Financial increased its Veracyte (VCYT) stake by 4,500% in Q3 2026, buying an estimated $2.17K and bringing the position to 46 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Dunhill Financial first reported a position in VCYT in Q4 2025 and has held it in 4 quarters since. The position peaked at $80 in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Dunhill Financial held 46 shares of Veracyte worth $63 as of Q3 2026.
  • Dunhill Financial bought 45 Veracyte shares in Q3 2026, an estimated $2.17K.
  • Veracyte made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1591 holding.
  • Dunhill Financial first reported a position in Veracyte in Q4 2025 and has held it in 4 quarters since.
  • Dunhill Financial's Veracyte position peaked at $80 in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.